Osaic Holdings’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$318K Buy
54,756
+2,471
+5% +$16.4K ﹤0.01% 3771
2025
Q4
$410K Buy
52,285
+11,934
+30% +$93.9K ﹤0.01% 3512
2025
Q3
$325K Sell
40,351
-2,358
-6% -$15.7K ﹤0.01% 3790
2025
Q2
$199K Buy
42,709
+3,774
+10% +$17.3K ﹤0.01% 3945
2025
Q1
$214K Sell
38,935
-4,886
-11% -$19.7K ﹤0.01% 3566
2024
Q4
$149K Buy
43,821
+867
+2% +$2.79K ﹤0.01% 3867
2024
Q3
$122K Buy
42,954
+5,454
+15% +$14K ﹤0.01% 4069
2024
Q2
$84.4K Buy
37,500
+11,927
+47% +$24K ﹤0.01% 4271
2024
Q1
$56.5K Buy
25,573
+7,150
+39% +$18.5K ﹤0.01% 4661
2023
Q4
$43.3K Sell
18,423
-3,611
-16% -$6.66K ﹤0.01% 4999
2023
Q3
$41K Buy
22,034
+5,627
+34% +$12.9K ﹤0.01% 5123
2023
Q2
$43K Buy
16,407
+5,500
+50% +$14K ﹤0.01% 5033
2023
Q1
$17.8K Hold
10,907
﹤0.01% 5635
2022
Q4
$15K Sell
10,907
-15,425
-59% -$21.8K ﹤0.01% 5751
2022
Q3
$41K Sell
26,332
-400
-1% -$662 ﹤0.01% 5052
2022
Q2
$42K Buy
26,732
+22,632
+552% +$47.8K ﹤0.01% 5091
2022
Q1
$11K Sell
4,100
-34,673
-89% -$84.7K ﹤0.01% 6094
2021
Q4
$113K Buy
38,773
+10,697
+38% +$23.1K ﹤0.01% 4496
2021
Q3
$69K Sell
28,076
-3,559
-11% -$10.3K ﹤0.01% 4854
2021
Q2
$129K Buy
31,635
+7,515
+31% +$28.7K ﹤0.01% 4259
2021
Q1
$109K Buy
24,120
+16,350
+210% +$88.2K ﹤0.01% 4271
2020
Q4
$39K Buy
7,770
+4,000
+106% +$20K ﹤0.01% 4743
2020
Q3
$22K Buy
3,770
+200
+6% +$800 ﹤0.01% 4865
2020
Q2
$9K Buy
+3,570
New +$12.4K ﹤0.01% 5244

Other funds holding XERS